Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 GBX | -1.47% | -8.22% | -21.18% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Sales 2024 * | 1.15M 1.44M | Sales 2025 * | - | Capitalization | 3.19M 4.01M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 2.78 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.2
x | P/E ratio 2025 * |
-
| Employees | 48 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.63% |
1 day | -1.47% | ||
1 week | -8.22% | ||
Current month | +3.88% | ||
1 month | -14.10% | ||
3 months | -27.96% | ||
6 months | -31.63% | ||
Current year | -21.18% |
Managers | Title | Age | Since |
---|---|---|---|
Adrian Kinkaid
CEO | Chief Executive Officer | 57 | 22-08-14 |
Stephen Smyth
DFI | Director of Finance/CFO | 49 | 23-08-23 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colin Walsh
BRD | Director/Board Member | 68 | 06-12-31 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Richard Buick
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.35 | -1.47% | 869,509 |
24-05-02 | 3.4 | +3.82% | 755,769 |
24-05-01 | 3.275 | +1.55% | 1,718,988 |
24-04-30 | 3.225 | -9.15% | 2,264,001 |
24-04-29 | 3.55 | -2.74% | 340,618 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.18% | 4.01M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- FAB Stock